4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE structure
|
Common Name | 4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE | ||
|---|---|---|---|---|
| CAS Number | 864754-10-9 | Molecular Weight | 363.25600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H30BNO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]morpholine |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C19H30BNO5 |
|---|---|
| Molecular Weight | 363.25600 |
| Exact Mass | 363.22200 |
| PSA | 49.39000 |
| LogP | 1.64330 |
|
~%
4-(2-[2-METHOXY... CAS#:864754-10-9 |
| Literature: HUTCHISON MEDIPHARMA LIMITED; Su, Wei-Guo; Deng, Wei; Ji, Jianguo Patent: US2014/121200 A1, 2014 ; Location in patent: Paragraph 0176; 0179; 0180 ; |
| 4-{2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL}-MORPHOLINE |
| Morpholine,4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl] |